AU2015289474B2 - Controllable self-annealing microgel particles for biomedical applications - Google Patents

Controllable self-annealing microgel particles for biomedical applications Download PDF

Info

Publication number
AU2015289474B2
AU2015289474B2 AU2015289474A AU2015289474A AU2015289474B2 AU 2015289474 B2 AU2015289474 B2 AU 2015289474B2 AU 2015289474 A AU2015289474 A AU 2015289474A AU 2015289474 A AU2015289474 A AU 2015289474A AU 2015289474 B2 AU2015289474 B2 AU 2015289474B2
Authority
AU
Australia
Prior art keywords
microgel particles
tissue
annealing
scaffold
spherical microgel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015289474A
Other languages
English (en)
Other versions
AU2015289474A1 (en
Inventor
Dino Di Carlo
Donald R. GRIFFIN
Philip SCUMPIA
Tatiana Segura
Westbrook WEAVER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California, San Diego filed Critical University of California Berkeley
Publication of AU2015289474A1 publication Critical patent/AU2015289474A1/en
Application granted granted Critical
Publication of AU2015289474B2 publication Critical patent/AU2015289474B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AU2015289474A 2014-07-17 2015-07-17 Controllable self-annealing microgel particles for biomedical applications Active AU2015289474B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462025844P 2014-07-17 2014-07-17
US62/025,844 2014-07-17
US201462059463P 2014-10-03 2014-10-03
US62/059,463 2014-10-03
US201562103002P 2015-01-13 2015-01-13
US62/103,002 2015-01-13
PCT/US2015/040962 WO2016011387A1 (en) 2014-07-17 2015-07-17 Controllable self-annealing microgel particles for biomedical applications

Publications (2)

Publication Number Publication Date
AU2015289474A1 AU2015289474A1 (en) 2017-02-02
AU2015289474B2 true AU2015289474B2 (en) 2019-12-05

Family

ID=55079098

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015289474A Active AU2015289474B2 (en) 2014-07-17 2015-07-17 Controllable self-annealing microgel particles for biomedical applications

Country Status (11)

Country Link
US (7) US20160279283A1 (enExample)
EP (1) EP3169372B1 (enExample)
JP (3) JP6651500B2 (enExample)
KR (4) KR102264607B1 (enExample)
CN (2) CN111939316B (enExample)
AU (1) AU2015289474B2 (enExample)
BR (1) BR112017000813B1 (enExample)
CA (1) CA2955357A1 (enExample)
ES (1) ES3002759T3 (enExample)
IL (2) IL282559B (enExample)
WO (1) WO2016011387A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102089388B (zh) 2008-04-30 2014-09-03 莱特高级沥青系统公司 橡胶改性的沥青膏及其乳液的预处理系统和方法
WO2010036341A1 (en) 2008-09-24 2010-04-01 Wright Asphalt Products Company System and method for high throughput preparation of rubber-modified asphalt cements
IL282559B (en) * 2014-07-17 2022-07-01 Univ California Controllable self-annealing microgel particles for biomedical applications
GB201514788D0 (en) * 2015-08-20 2015-10-07 Ecole Polytech Malleable scaffold material and uses thereof
WO2017136427A1 (en) * 2016-02-02 2017-08-10 The Regents Of The University Of California Hydrogel for endogenous neuroprogenitor cell recruitment
WO2017142879A1 (en) 2016-02-16 2017-08-24 The Regents Of The University Of California Methods for immune system modulation with microporous annealed particle gels
US10849988B2 (en) 2016-04-08 2020-12-01 The Regents Of The University Of California Hydrogel for engineered immune response to D-chirality peptides
CA3030558A1 (en) 2016-07-12 2018-01-18 Northeastern University Single cell fluorescence in situ hybridization in microfluidic droplets
JP6345736B2 (ja) * 2016-07-15 2018-06-20 国立研究開発法人科学技術振興機構 液滴安定化装置、液滴分取装置及びそれらの方法
WO2018136205A1 (en) * 2016-12-29 2018-07-26 Tempo Therapeutics, Inc. Methods and systems for treating a site of a medical implant
WO2018144481A1 (en) 2017-01-31 2018-08-09 The Regents Of The University Of California Multi-arm block-copolymers for multifunctional self-assembled systems
DK4218738T3 (da) 2017-02-24 2024-11-11 Univ California Partikeldråbestrukturer og fremgangsmåder til fremstilling og anvendelse af disse
US11131673B2 (en) 2017-04-27 2021-09-28 Northeastern University Live single-cell bioassay in microdroplets
US11129790B2 (en) 2017-05-19 2021-09-28 Northeastern University Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
WO2019068206A1 (en) 2017-10-05 2019-04-11 Ecole Polytechnique Federale De Lausanne (Epfl) APPROPRIATE PARTICLE FOR MANUFACTURING IMPLANTABLE TISSUE GENIUS ENGINEERING EQUIPMENT
WO2019191299A1 (en) 2018-03-27 2019-10-03 San Diego State University In situ partially degradable separation interface for fabrication of complex near net shape objects by pressure assisted sintering
EP3773770B1 (en) 2018-04-13 2023-11-29 University of Virginia Patent Foundation Compositions and methods for preparing and using non-immunogenic fast annealing microporous annealed particle hydrogels
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
WO2020146031A1 (en) * 2018-10-18 2020-07-16 The Regents Of The University Of California Methods for fabricating modular hydrogels from macromolecules with orthogonal physico-chemical responsivity
WO2020198888A1 (en) 2019-04-02 2020-10-08 Volumina Medical Sa Composition comprising a cross-linked polyol
EP3789049A1 (en) * 2019-09-06 2021-03-10 QGel SA Method for obtaining healthy intestinal organoids
WO2021113812A1 (en) * 2019-12-06 2021-06-10 University Of Virginia Patent Foundation Injectable micro-annealed porous scaffold for articular cartilage regeneration
US20230092795A1 (en) * 2020-02-28 2023-03-23 University Of Florida Research Foundation, Inc. Compositions, methods, kits, and systems relating to charge-neutral microgels for 3d cell culture and printing
JP2021171180A (ja) * 2020-04-21 2021-11-01 株式会社ユニバーサルエンターテインメント 遊技機
WO2022016013A1 (en) * 2020-07-16 2022-01-20 The Regents Of The University Of California Injectable drug-releasing microporous annealed particle scaffolds for treating myocardial infarction
US12280540B2 (en) 2020-09-27 2025-04-22 San Diego State University Research Foundation In situ partially degradable separation interface for fabrication of complex near net shape objects by pressure assisted sintering
US11879118B2 (en) * 2020-11-10 2024-01-23 C.C. Imex Gel tray for bacteria transformation lab
US20250264477A1 (en) 2021-04-14 2025-08-21 Partillion Bioscience Corporation Nanoscale reaction chambers and methods of using the same
US20240181137A1 (en) * 2021-05-27 2024-06-06 The Regents Of The University Of California Superporous Gel Matrix for Encapsulation of Cells
WO2023004019A1 (en) * 2021-07-21 2023-01-26 President And Fellows Of Harvard College Methods of crosslinking polymers and hydrogel microparticles and of encapsulating biologically active compounds, compositions made therefrom and devices
KR20230059380A (ko) * 2021-10-26 2023-05-03 강원대학교산학협력단 피부 복원용 3차원 스캐폴드
WO2023192343A1 (en) * 2022-03-29 2023-10-05 The Penn State Research Foundation Bioactive granular hydrogel scaffolds and use thereof
WO2023215479A1 (en) * 2022-05-04 2023-11-09 Massachusetts Institute Of Technology Formulations and medical devices for minimally-invasive deep tissue applications
WO2024015656A1 (en) * 2022-07-11 2024-01-18 The Regents Of The University Of California Cell-microgel encapsulation in injectable formulations
US20240026088A1 (en) 2022-07-19 2024-01-25 CellDrop Biosciences, Inc. Hydrogel Particle Encapsulation and Suspension Media Removal
WO2024030599A1 (en) * 2022-08-04 2024-02-08 Duke University Technologies for scaffold and void space analysis of granular particle scaffolds
WO2024036108A1 (en) * 2022-08-09 2024-02-15 Bionaut Labs Ltd. Devices, systems, and methods for the treatment of malignant neoplasm disorders using controlled release devices
CN116077736A (zh) * 2022-09-26 2023-05-09 四川大学 基于多孔明胶复合微球的可注射骨修复支架及其制备方法
WO2025054494A1 (en) * 2023-09-08 2025-03-13 Rasyn, Llc Multi-omic analysis using capture particle aggregation
CN117462751A (zh) * 2023-10-30 2024-01-30 南京鼓楼医院 一种甲基丙烯酰化明胶微孔退火颗粒支架及其制备方法
WO2025096900A1 (en) * 2023-11-03 2025-05-08 Board Of Regents, The University Of Texas System Synthetic network materials and methods of making and use thereof
CN117771433B (zh) * 2023-12-27 2026-06-23 西安交通大学 具有可缓释药物的明胶微球的骨修复复合材料及制备方法
WO2025247844A1 (en) 2024-05-28 2025-12-04 Eth Zurich Granular hydrogel combinations for wound healing
WO2026154764A1 (ja) * 2025-01-20 2026-07-23 国立研究開発法人科学技術振興機構 選択的分解性ポリマー微粒子成形体、並びにその製造方法及び分解方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193536A1 (en) * 2006-08-14 2008-08-14 Alireza Khademhosseini Cell-Laden Hydrogels
WO2011101684A1 (en) * 2010-02-19 2011-08-25 The University Of Manchester Microgel compositions
WO2013071126A1 (en) * 2011-11-10 2013-05-16 The Regents Of The University Of California Enzyme-assisted spatial decoration of biomaterials

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4726877A (en) * 1986-01-22 1988-02-23 E. I. Du Pont De Nemours And Company Methods of using photosensitive compositions containing microgels
US4753865A (en) 1986-01-22 1988-06-28 E. I. Du Pont De Nemours And Company Photosensitive compositions containing microgels
US5213580A (en) 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5124188A (en) 1990-04-02 1992-06-23 The Procter & Gamble Company Porous, absorbent, polymeric macrostructures and methods of making the same
DE69329594T2 (de) 1992-02-28 2001-05-31 Board Of Regents, The University Of Texas System Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung
JP3156955B2 (ja) * 1995-07-12 2001-04-16 大日精化工業株式会社 連結されたミクロゲル粒子の製造方法及びそれで処理された物品
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US5854382A (en) * 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
US6316522B1 (en) 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US6007833A (en) 1998-03-19 1999-12-28 Surmodics, Inc. Crosslinkable macromers bearing initiator groups
US7547445B2 (en) 1998-03-19 2009-06-16 Surmodics, Inc. Crosslinkable macromers
US6410044B1 (en) 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
AU752255B2 (en) 1998-10-23 2002-09-12 Polyheal Ltd. Compositions of microspheres for wound healing
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
ES2383122T3 (es) 1999-08-27 2012-06-18 Angiodevice International Gmbh Dispositivo de polímero biocompatible
DE60135019D1 (de) * 2000-11-17 2008-09-04 Univ Virginia Commonwealth Elektroverarbeitetes kollagen
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
US6669827B2 (en) 2001-06-18 2003-12-30 Austin & Neff, L.L.C. Systems and methods for affecting the ultra-fast photodissociation of water molecules
GB0115320D0 (en) * 2001-06-22 2001-08-15 Univ Nottingham Matrix
US20040258731A1 (en) 2001-11-21 2004-12-23 Tsuyoshi Shimoboji Preparation approriate for cartilage tissue formation
US7745532B2 (en) 2002-08-02 2010-06-29 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US20040147016A1 (en) 2002-09-30 2004-07-29 Rowley Jonathan A. Programmable scaffold and methods for making and using the same
US8574204B2 (en) 2002-10-21 2013-11-05 Angiodynamics, Inc. Implantable medical device for improved placement and adherence in the body
US7820737B2 (en) * 2003-03-13 2010-10-26 Eugenia Kumacheva Method of producing hybrid polymer-inorganic materials
CN1864114A (zh) 2003-06-30 2006-11-15 优力半导体有限公司 用于电源电流感测及压降损失补偿的可编程校正电路
EP1670385B1 (en) 2003-10-01 2013-01-23 University of Washington Novel porous biomaterials
ATE524203T1 (de) 2003-11-03 2011-09-15 Medtronic Inc Hydrogel für zellspezifisches einwachsen
AU2005318097A1 (en) * 2004-12-22 2006-06-29 Kuros Biosurgery Ag Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors
US20070141105A1 (en) 2005-10-07 2007-06-21 Cambrex Bio Science Walkersville, Inc. Engineered Biological Matrices
GB2431104A (en) 2005-10-10 2007-04-18 Univ Greenwich Microgel particles grafted to a substrate
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
US8029575B2 (en) 2005-10-25 2011-10-04 Globus Medical, Inc. Porous and nonporous materials for tissue grafting and repair
WO2007070660A2 (en) 2005-12-13 2007-06-21 President And Fellows Of Harvard College Scaffolds for cell transplantation
EP1808187A1 (en) * 2006-01-11 2007-07-18 Straumann Holding AG Cell selective implant surface with controlled release of bioactive agents
CA2639921C (en) 2006-01-23 2014-01-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Microspheres comprising nanocapsules containing a lipophilic drug
US20070212385A1 (en) 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
DE102006040772A1 (de) 2006-08-31 2008-03-20 Kist-Europe Forschungsgesellschaft Mbh Polymermatrix, Verfahren zu deren Herstellung sowie deren Verwendung
GB0701896D0 (en) * 2007-02-01 2007-03-14 Regentec Ltd Composition
US8277832B2 (en) * 2007-10-10 2012-10-02 The University Of Kansas Microsphere-based materials with predefined 3D spatial and temporal control of biomaterials, porosity and/or bioactive signals
US20090294049A1 (en) 2008-06-02 2009-12-03 Medtronic Vascular, Inc. Biodegradable Adhesive Hydrogels
AU2009268923B2 (en) 2008-06-16 2015-09-17 Pfizer Inc. Drug loaded polymeric nanoparticles and methods of making and using same
US8557288B2 (en) 2008-08-15 2013-10-15 Washington University Hydrogel microparticle formation in aqueous solvent for biomedical applications
US20120015440A1 (en) 2008-09-08 2012-01-19 Tokyo University Of Science Educational Foundation Administrative Org. Spheroid composite, spheroid-containing hydrogel and processes for production of same
US11090387B2 (en) 2008-12-22 2021-08-17 The Trustees Of The University Of Pennsylvania Hydrolytically degradable polysaccharide hydrogels
LT2459220T (lt) 2009-07-31 2020-12-28 Ascendis Pharma A/S Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
CA2781518C (en) 2009-11-25 2016-08-23 Healionics Corporation Granules of porous biocompatible materials
KR101813300B1 (ko) 2010-04-08 2017-12-28 힐리오닉스 코포레이션 미세다공성 표면 층을 가지는 이식형 의료 장치 및 이에 대한 이물 반응을 감소시키는 방법
US20110256628A1 (en) 2010-04-20 2011-10-20 The University Of Washington Through Its Center For Commercialization Adaptive tissue engineering scaffold
US8524215B2 (en) 2010-08-02 2013-09-03 Janssen Biotech, Inc. Absorbable PEG-based hydrogels
HRP20200310T1 (hr) 2010-10-06 2020-08-21 President And Fellows Of Harvard College Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
EP2641094B1 (en) 2010-11-18 2019-03-06 The Regents of The University of California Method for high-throughput solution exchange for cell and particle suspensions
WO2012068003A2 (en) 2010-11-18 2012-05-24 The Regents Of The University Of California Particle focusing systems and methods
US9234171B2 (en) 2010-12-08 2016-01-12 Rutgers, The State University Of New Jersey Stem cell differentiation using novel light-responsive hydrogels
US20120202263A1 (en) 2011-02-03 2012-08-09 The Trustees Of The University Of Pennsylvania Bioactive Macromers and Hydrogels and Methods for Producing Same
US10260039B2 (en) * 2011-05-11 2019-04-16 Massachusetts Institute Of Technology Microgels and microtissues for use in tissue engineering
US20130143056A1 (en) 2011-06-08 2013-06-06 Surmodics, Inc. Photo-vinyl linking agents
US9993440B2 (en) 2011-09-02 2018-06-12 The Regents Of The University Of California Enzyme responsive nanocapsules for protein delivery
US20140230909A1 (en) 2011-09-30 2014-08-21 The Regents Of The University Of California Devices and methods for programming fluid flow using sequenced microstructures
KR101820792B1 (ko) * 2011-12-20 2018-01-23 한온시스템 주식회사 차량 공조장치용 컨트롤러
EP2882465B1 (en) * 2012-08-08 2019-05-08 Nanyang Technological University Methods of manufacturing hydrogel microparticles having living cells, and compositions for manufacturing a scaffold for tissue engineering
US10201613B2 (en) 2012-09-07 2019-02-12 The Regents Of The University Of California Method of creating hydrogels through oxime bond formation
US9364543B2 (en) 2012-10-24 2016-06-14 Indiana University Research And Technology Corporation Visible light curable hydrogels and methods for using
EP2801613A1 (en) 2013-05-08 2014-11-12 Ecole Polytechnique Fédérale de Lausanne (EPFL) Arrays of discrete cell culture microenvironments, methods of making such arrays and uses thereof
US9381217B2 (en) 2013-09-09 2016-07-05 Georgia Tech Research Corporation Microgels for encapsulation of cells and other biologic agents
US20150290362A1 (en) 2014-04-10 2015-10-15 Georgia Tech Research Corporation Hybrid fibrin-microgel constructs for tissue repair and regeneration
IL282559B (en) 2014-07-17 2022-07-01 Univ California Controllable self-annealing microgel particles for biomedical applications
WO2016096054A1 (en) 2014-12-19 2016-06-23 Ecole Polytechnique Federale De Lausanne (Epfl) Method and device for mixing two streams of droplets
US20160303281A1 (en) 2015-04-17 2016-10-20 Rochal Industries, Llc Composition and kits for pseudoplastic microgel matrices
WO2017127717A1 (en) 2016-01-21 2017-07-27 The Regents Of The University Of California Device and method for analyte sensing with microporous annealed particle gels
WO2017136427A1 (en) 2016-02-02 2017-08-10 The Regents Of The University Of California Hydrogel for endogenous neuroprogenitor cell recruitment
WO2017142879A1 (en) 2016-02-16 2017-08-24 The Regents Of The University Of California Methods for immune system modulation with microporous annealed particle gels
WO2018136205A1 (en) 2016-12-29 2018-07-26 Tempo Therapeutics, Inc. Methods and systems for treating a site of a medical implant

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193536A1 (en) * 2006-08-14 2008-08-14 Alireza Khademhosseini Cell-Laden Hydrogels
WO2011101684A1 (en) * 2010-02-19 2011-08-25 The University Of Manchester Microgel compositions
WO2013071126A1 (en) * 2011-11-10 2013-05-16 The Regents Of The University Of California Enzyme-assisted spatial decoration of biomaterials

Also Published As

Publication number Publication date
KR20220104071A (ko) 2022-07-25
JP7188779B2 (ja) 2022-12-13
AU2015289474A1 (en) 2017-02-02
ES3002759T3 (en) 2025-03-07
US11464886B2 (en) 2022-10-11
US20180078671A1 (en) 2018-03-22
US20200085859A1 (en) 2020-03-19
CN111939316B (zh) 2022-08-05
CA2955357A1 (en) 2016-01-21
JP2017522113A (ja) 2017-08-10
IL282559A (en) 2021-06-30
JP2022177012A (ja) 2022-11-30
US10912860B2 (en) 2021-02-09
KR102614915B1 (ko) 2023-12-19
JP7627498B2 (ja) 2025-02-06
KR20230173741A (ko) 2023-12-27
EP3169372A4 (en) 2018-03-21
CN106714854B (zh) 2020-09-04
EP3169372A1 (en) 2017-05-24
KR20170031741A (ko) 2017-03-21
EP3169372B1 (en) 2024-09-04
KR102421923B1 (ko) 2022-07-18
KR20210072133A (ko) 2021-06-16
US20230190995A1 (en) 2023-06-22
CN106714854A (zh) 2017-05-24
US20170368224A1 (en) 2017-12-28
WO2016011387A1 (en) 2016-01-21
CN111939316A (zh) 2020-11-17
IL250092A0 (en) 2017-03-30
KR102264607B1 (ko) 2021-06-14
US20190151497A1 (en) 2019-05-23
BR112017000813A2 (pt) 2017-12-05
BR112017000813B1 (pt) 2021-03-16
IL250092B (en) 2021-05-31
KR102758574B1 (ko) 2025-01-21
US20210138105A1 (en) 2021-05-13
JP6651500B2 (ja) 2020-02-19
US20160279283A1 (en) 2016-09-29
JP2020075150A (ja) 2020-05-21
IL282559B (en) 2022-07-01

Similar Documents

Publication Publication Date Title
US11464886B2 (en) Controllable self-annealing microgel particles for biomedical applications
Sanz-Horta et al. Technological advances in fibrin for tissue engineering
Singh et al. Natural polymer-based hydrogels as scaffolds for tissue engineering
Tallawi et al. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review
Meco et al. Impact of elastin-like protein temperature transition on PEG-ELP hybrid hydrogel properties
JP2009502364A (ja) 生体適合性ポリマーおよび使用方法
US20190060522A1 (en) Natural Polymer-Derived Scaffold Material and Methods for Production Thereof
US10849988B2 (en) Hydrogel for engineered immune response to D-chirality peptides
Werner et al. Modulating extracellular matrix at interfaces of polymeric materials
WO2022016013A1 (en) Injectable drug-releasing microporous annealed particle scaffolds for treating myocardial infarction
de Magalhães Bioengineering a 3D Breast Tumor Angiogenesis Model
Kyburz Bio-Functionalized PEG Hydrogels to Study and Direct Mesenchymal Stem Cell Migration and Differentiation
Ndreu-Halili Cell/Tissue Microenvironment Engineering and Monitoring in Tissue Engineering, Regenerative Medicine, and In Vitro Tissue Models

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)